ArticleCancer letters2018

Cell surface vimentin-targeted monoclonal antibody 86C increases sensitivity to temozolomide in glioma stem cells.

Hyangsoon Noh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.